Since 2005 Beth Seidenberg, general partner of Kleiner Perkins, announced new money Westlake Village BioPartners.
The Los Angeles-based company raised $ 320 million to incubate and invest in the special field of early career life sciences company Seidenberg.
A spokesman for Westlake Village, this morning's news, I confirmed that she is "going out" by Kleiner Perkins.
Seidenberg was one of the company's most important female partners and was a major biotechnology investor in Silicon Valley. According to the profile of LinkedIn, she is a member of the Board of Directors of 3-V Biosciences, Atara, Breathe Technologies, Epizyme, ExpansionRx, FLX, Research and Development. Hixme and Kinsa.
Kleiner Perkins' COO, Scott Ryles also joined Westlake Village as COO. And in January, Sean Harper, executive vice president and R & D manager of Amgen, plans to join the company. Seidenberg was formerly Amgen 's medical director and global development manager.
"Pursuing passion for life science and creating funds with an excellent team that I have worked closely with is an explosive view of my role of Kleiner Perkins and scientific and medical breakthrough From, "Seidenberg said in a statement. "Sean and I have known each other for over 20 years, bring unique knowledge and expertise to the field of drug discovery and development, and provide a complete common story to build West Lake.
We do not know …
I hope you like the above news
Beth Seidenberg, an investor of Kleiner Perkins for many years, raised $ 320 million with his own funds. news
. Stay Tuned For More Updates :)